Immune Intervention With Rituximab to Preserve Beta Cell Function in Early Onset Type 1 Diabetes

NCT01280682 · clinicaltrials.gov ↗
PHASE4
Phase
COMPLETED
Status
120
Enrollment
OTHER
Sponsor class

Conditions

Interventions

Sponsor

Yang Tao